NCT03427931View on ClinicalTrials.gov

CGM Use in Islet Transplant Recipients

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

July 11, 2019

Study Completion Date

July 11, 2019

Conditions
Islet TransplantationType1 Diabetes Mellitus
Interventions
OTHER

Continuous Glucose Monitor (CGM)

Study subjects will collect Continuous Glucose Monitor data for a minimum of 28 days but may continue for up to 3 months.

Trial Locations (1)

22903

University of Virginia Center for Diabetes Technology, Charlottesville

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

University of Virginia

OTHER

NCT03427931 - CGM Use in Islet Transplant Recipients | Biotech Hunter | Biotech Hunter